Leader-Containing Uncapped Viral Transcript Activates RIG-I in Antiviral Stress Granules

RIG-I triggers antiviral responses by recognizing viral RNA (vRNA) in the cytoplasm. However, the spatio-temporal dynamics of vRNA sensing and signal transduction remain elusive. We investigated the time course of events in cells infected with Newcastle disease virus (NDV), a non-segmented negative-...

Full description

Saved in:
Bibliographic Details
Published inPLoS pathogens Vol. 12; no. 2; p. e1005444
Main Authors Oh, Seong-Wook, Onomoto, Koji, Wakimoto, Mai, Onoguchi, Kazuhide, Ishidate, Fumiyoshi, Fujiwara, Takahiro, Yoneyama, Mitsutoshi, Kato, Hiroki, Fujita, Takashi
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 10.02.2016
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:RIG-I triggers antiviral responses by recognizing viral RNA (vRNA) in the cytoplasm. However, the spatio-temporal dynamics of vRNA sensing and signal transduction remain elusive. We investigated the time course of events in cells infected with Newcastle disease virus (NDV), a non-segmented negative-strand RNA virus. RIG-I was recruited to viral replication complexes (vRC) and triggered minimal primary type I interferon (IFN) production. RIG-I subsequently localized to antiviral stress granules (avSG) induced after vRC formation. The inhibition of avSG attenuated secondary IFN production, suggesting avSG as a platform for efficient vRNA detection. avSG selectively captured positive-strand vRNA, and poly(A)+ RNA induced IFN production. Further investigations suggested that uncapped vRNA derived from read-through transcription was sensed by RIG-I in avSG. These results highlight how viral infections stimulate host stress responses, thereby selectively recruiting uncapped vRNA to avSG, in which RIG-I and other components cooperate in an efficient antiviral program.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
I have read the journal's policy and the authors of this manuscript have the following competing interests: FI is employed by Carl Zeiss MicroImaging Co., Ltd. as a senior scientific advisor. This does not alter our adherence to all PLOS Pathogens policies on sharing data and materials.
Conceived and designed the experiments: SO MY HK TFujit. Performed the experiments: SO. Analyzed the data: KOnom MW KOnog. Contributed reagents/materials/analysis tools: FI TFujiw. Wrote the paper: SO MW HK TFujit.
ISSN:1553-7374
1553-7366
1553-7374
DOI:10.1371/journal.ppat.1005444